Candy Preferences to Pharma Insights

This chapter starts with a playful debate on candy preferences, transitioning into a serious analysis of Lilly's earnings report and its implications due to market dynamics and supply chain issues. It examines recent performances in the pharmaceutical sector, focusing on obesity drugs and market competition among companies like Pfizer, Amgen, and Merck.